Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine

NCT00345358 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Streptococcal

Interventions

BIOLOGICAL: Synflorix
BIOLOGICAL: Infanrix IPV/Hib

Sponsor

GlaxoSmithKline